Yahoo
Mail
Summary
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
MEDXF - Medexus Pharmaceuticals Inc.
Other OTC - Other OTC Delayed Price. Currency in USD
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2022
31/03/2021
31/03/2020
Total revenue
99,726
76,701
79,660
52,432
Cost of revenue
44,591
38,774
37,655
22,990
Gross profit
55,135
37,927
42,005
29,442
Operating expenses
Research development
3,044
5,873
4,596
1,098
Selling general and administrative
46,756
44,032
36,172
28,934
Total operating expenses
50,174
50,303
41,274
30,482
Operating income or loss
4,961
-12,376
731
-1,041
Interest expense
13,101
12,223
9,819
6,442
Total other income/expenses net
-522
20,779
-22,416
3,254
Income before tax
-8,662
-3,820
-31,501
-5,188
Income tax expense
2,260
-941
-3,237
-790.4386
Income from continuing operations
-10,922
-2,879
-28,264
-4,397
Net income
-10,922
-2,879
-28,264
-4,397
Net income available to common shareholders
-10,922
-2,879
-28,264
-4,397
Basic EPS
-
-0.15
-1.86
-0.33
Diluted EPS
-
-0.15
-1.86
-0.33
Basic average shares
-
19,454
15,197
14,360
Diluted average shares
-
19,454
15,197
14,360
EBITDA
-
14,548
-15,704
4,961
Data Disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About Our Ads
© 2023 Yahoo. All rights reserved.
Finance
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
All Markets Summit
My Screeners